Opposition To Perpetuals Is About Structure: Duffy

CME Group CEO Terry Duffy discussed commodity exchanges urging U.S. regulators to withhold approval of Kalshi’s proposed perpetual oil futures contract. The exchanges are also pressing regulators to potentially close a loophole that gives retail traders access to offshore platforms; no regulatory decision or market impact was reported.

Analysis

The economic question is whether regulators protect the regulated-exchange moat or merely slow a competing product. If approval is withheld, CME and other incumbent venues could retain retail and institutional flow; if the offshore-access loophole is closed, some activity may migrate to US-regulated venues. But neither outcome guarantees CME captures it: product design, distribution, liquidity, and clearing requirements will determine where volume lands, with Intercontinental Exchange also a potential beneficiary. A permitted perpetual oil contract could pressure incumbent economics at the margin by offering continuous exposure without conventional futures rolls, though its funding and settlement mechanics may limit adoption among hedgers and institutions.

Near term, this is a lobbying and regulatory-process story, not evidence of a change in CME earnings. The 1–3 month catalyst is the regulator’s treatment of the proposed contract and any rulemaking on offshore retail access. Over 6–18 months, the structural issue is whether regulators permit onshore perpetual products and whether retail demand translates into durable, cleared volume. The contrarian risk to the incumbent-protection thesis: restrictions could invite scrutiny of exchange lobbying and antitrust concerns, while pushing activity offshore rather than to CME. No trade is warranted from this signal alone. Verify the contract’s proposed venue, regulator and approval path, and any disclosed volume or fee economics before underwriting material revenue impact. The thesis weakens if approval proceeds or if access restrictions do not redirect trading to regulated exchanges.

Key Decisions for Investors

• Do not trade CME on this headline alone; the impact is conditional and the article provides no evidence of volume, revenue, or guidance changes.
• Monitor regulator filings and decisions over the next 1–3 months: denial or material delay could support the incumbent-exchange moat, while approval would challenge it.
• Track CME and Intercontinental Exchange disclosures for retail participation, relevant contract volumes, and fee contribution; treat actual flow migration—not lobbying statements—as the proof point.
• Revisit a relative long in incumbent exchanges only if rules demonstrably redirect offshore activity to cleared US venues; falsify that thesis if access restrictions leave activity offshore or a competing onshore venue captures the flow.